West Nile Virus Envelope Protein (Intermediate Domain) Blocking
- -
- -
Antibody DetailsProduct DetailsReactive Species Virus Product Concentration 0.2 mg/ml Amino Acid Location 15 amino acids near the middle of WNV Envelope protein. Formulation This peptide is formulated in PBS pH 7.2 (0.01 M Sodium Phosphate, 0.13 M NaCl) containing 0.1% bovine serum albumin and 0.02% sodium azide. Storage and Handling Store this peptide in working aliquots at -20°C in a manual defrost freezer. Avoid Repeated Freeze Thaw Cycles. Country of Origin USA Shipping Next Day Ambient Each investigator should determine their own optimal working dilution for specific applications. See directions on lot specific datasheets, as information may periodically change. DescriptionBackground West Nile Virus Envelope Protein peptide is applicable as a control peptide for blocking antibody binding in Western blotting. Research Area Category B Pathogens . Infectious Disease . Viral . West Nile References & Citations1. Malmgaard L. Induction and regulation of IFNs during viral infections. J. Interferon & Cyto. Res. 2004; 24:439-54
2. Au WC, Moore PA, Lowther W, et al. Identification of a member of the interferon regulatory factor family that binds to the interferon-stimulated response element and activates expression of interferon-induced genes. Proc. Natl. Acad. Sci. USA 1995; 92:11657-61.
3. Fitzgerald KA, McWhirter SM, Faia KL, et al. IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway. Nat. Immunol. 2003; 4:491-6.
4. Sharma S, Tenoever BR, Grandvaux N, et al. Triggering the interferon antiviral response through an IKK-related pathway. Science 2003; 300:1148-51. Technical ProtocolsCertificate of Analysis |
Related Products
- -
- -
Prod No. | Description |
---|---|
W146 | |
W144 | |
W145 | |
W153 | |
W151 | |
W152 |
Products are for research use only. Not for use in diagnostic or therapeutic procedures.